Litchfield Caroline's Form 4 filing
Merck & Co., Inc. (MRK) · filed Feb 15, 2024
- Accession no.
- 0001127602-24-005196
- Filed
- Feb 15, 2024
- Trade date
- Feb 14, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.81M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Litchfield CarolineCIK 0001854928 | Officer (EVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Common Stock | MOption exerciseAcquired | +38,291 | $58.08 | +$2,223,941.28 | 89,199.19 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −38,291 | $125.50 | −$4,805,520.5 | 50,908.19 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Common Stock | MOption exerciseDisposed | −38,291 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.